Khaled A Elsaid

Summary

Affiliation: Massachusetts College of Pharmacy and Health Sciences
Country: USA

Publications

  1. pmc Pharmaceutical nanocarrier association with chondrocytes and cartilage explants: influence of surface modification and extracellular matrix depletion
    K A Elsaid
    Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA
    Osteoarthritis Cartilage 21:377-84. 2013
  2. doi request reprint The impact of forced joint exercise on lubricin biosynthesis from articular cartilage following ACL transection and intra-articular lubricin's effect in exercised joints following ACL transection
    K A Elsaid
    Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA
    Osteoarthritis Cartilage 20:940-8. 2012
  3. doi request reprint Initiative to improve thromboprophylactic enoxaparin exposure in hospitalized patients with renal impairment
    Khaled A Elsaid
    Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115 5896, USA
    Am J Health Syst Pharm 69:390-6. 2012

Collaborators

Detail Information

Publications3

  1. pmc Pharmaceutical nanocarrier association with chondrocytes and cartilage explants: influence of surface modification and extracellular matrix depletion
    K A Elsaid
    Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA
    Osteoarthritis Cartilage 21:377-84. 2013
    ....
  2. doi request reprint The impact of forced joint exercise on lubricin biosynthesis from articular cartilage following ACL transection and intra-articular lubricin's effect in exercised joints following ACL transection
    K A Elsaid
    Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA
    Osteoarthritis Cartilage 20:940-8. 2012
    ....
  3. doi request reprint Initiative to improve thromboprophylactic enoxaparin exposure in hospitalized patients with renal impairment
    Khaled A Elsaid
    Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115 5896, USA
    Am J Health Syst Pharm 69:390-6. 2012
    ..The impact of a quality-improvement (QI) initiative to decrease the risk of bleeding in renally impaired patients receiving enoxaparin prophylaxis for venous thromboembolism (VTE) was evaluated...